Thanks, Jim. What do you think the p-value is on the null hypothesis that HEB, PP, and INGN are just ordinary biotech companies, i.e. that each of these three pre-specified companies got an RTF on its lead drug program due to chance alone?
I would guess the p-value is <0.00001.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”